Literature DB >> 24757310

Effect of sodium chloride on efficiency of cisplatinum dissolved in dimethyl sulfoxide: an in vitro study.

Seyed Kazem Bagherpour Doun1, Sohrab Halal Khor2, Dardi Qujeq2, Hasan Ebrahimi Shahmabadi3, Seyed Ebrahim Alavi4, Fatemeh Movahedi5, Azim Akbarzadeh3.   

Abstract

Cisplatinum (Cispt) is an anti-cancer drug with a low level of solubility. One of Cispt's solvents is dimethyl sulfoxide (DMSO) which can be substituted with chlorine of drug as Cispt's solvent. Applying such a solvent in biological studies is impossible due to intense reduction in activity. On the other hand, it is specified that Cispt's stability is increased in aqueous media by increasing sodium chloride (NaCl) concentration up to 0.9 %. Consequently, we intended to study the effect of DMSO on cytotoxicity of Cispt in presence of sodium. MTT assay was employed to study cytotoxicity effect of Cispt + NaCl + DMSO and Cispt + DMSO on G-292 cell line. Cytotoxicity in dilutions of 300 and 9 (p < 0.01) of Cispt in Cispt + NaCl + DMSO formulation was equal to 78 and 7 %. These values were estimated 79 and 18 % for Cispt + DMSO formulation and 79 and 24 % for free drug. IC50 values demonstrated reduction of 45 % in cytotoxicity of Cispt in Cispt + DMSO formulation. Studying chemical structure of Cispt and Cispt dissolved in DMSO showed that NaCl cannot inhibit inactivating effect of DMSO on Cispt and effect of this solvent on Cispt is independent from presence of NaCl. Results represented that using NaCl does not result in stability and keeping cytotoxicity properties of Cispt in DMSO. Findings suggest more studies for using DMSO as a solvent of Cispt.

Entities:  

Keywords:  Cisplatinum; Cytotoxicity; Dimethyl sulfoxide; Sodium chloride

Year:  2013        PMID: 24757310      PMCID: PMC3990798          DOI: 10.1007/s12291-013-0361-9

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  15 in total

1.  Silymarin modulates Cisplatin-induced oxidative stress and hepatotoxicity in rats.

Authors:  Heba Hosny Mansour; Hafez Farouk Hafez; Nadia Mohamed Fahmy
Journal:  J Biochem Mol Biol       Date:  2006-11-30

2.  BNP7787-mediated modulation of paclitaxel- and cisplatin-induced aberrant microtubule protein polymerization in vitro.

Authors:  Aulma R Parker; Pavankumar N Petluru; Meizhen Wu; Min Zhao; Harry Kochat; Frederick H Hausheer
Journal:  Mol Cancer Ther       Date:  2010-08-31       Impact factor: 6.261

3.  Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro.

Authors:  Mohammad R Abedini; Qing Qiu; Xiaojuan Yan; Benjamin K Tsang
Journal:  Oncogene       Date:  2004-09-16       Impact factor: 9.867

4.  Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours.

Authors:  Mei Lin Tan; Peter F M Choong; Crispin R Dass
Journal:  Cancer Cell Int       Date:  2010-03-24       Impact factor: 5.722

5.  Cellular responses to Cisplatin-induced DNA damage.

Authors:  Alakananda Basu; Soumya Krishnamurthy
Journal:  J Nucleic Acids       Date:  2010-08-08

6.  Stress response inhibits the nephrotoxicity of cisplatin.

Authors:  Marie H Hanigan; Mei Deng; Lei Zhang; Peyton T Taylor; Maia G Lapus
Journal:  Am J Physiol Renal Physiol       Date:  2004-09-07

7.  Cisplatin and dimethyl sulfoxide react to form an adducted compound with reduced cytotoxicity and neurotoxicity.

Authors:  Stephanie J Fischer; Linda M Benson; Abdul Fauq; Stephen Naylor; Anthony J Windebank
Journal:  Neurotoxicology       Date:  2008-03-04       Impact factor: 4.294

8.  Neurotoxicity caused by the treatment with platinum analogues.

Authors:  Sousana Amptoulach; Nicolas Tsavaris
Journal:  Chemother Res Pract       Date:  2011-06-27

9.  Dimethyl sulfoxide (DMSO) exacerbates cisplatin-induced sensory hair cell death in zebrafish (Danio rerio).

Authors:  Phillip M Uribe; Melissa A Mueller; Julia S Gleichman; Matthew D Kramer; Qi Wang; Martha Sibrian-Vazquez; Robert M Strongin; Peter S Steyger; Douglas A Cotanche; Jonathan I Matsui
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

10.  Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluation.

Authors:  Laura Astolfi; Sara Ghiselli; Valeria Guaran; Milvia Chicca; Edi Simoni; Elena Olivetto; Giorgio Lelli; Alessandro Martini
Journal:  Oncol Rep       Date:  2013-02-06       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.